查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575307

狗疫苗市場：按疫苗類型、按技術、按最終用戶、按分銷管道、按應用、按年齡層、按狗大小 - 2025-2030 年全球預測

Dog Vaccines Market by Vaccine Type (Core Vaccines, Non-Core Vaccines), Technology (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年狗疫苗市值為20.5億美元，預計到2024年將達到22.1億美元，複合年成長率為8.03%，到2030年預計將達到35.2億美元。

由於寵物擁有量的增加、動物健康意識的提高以及獸醫學的進步，包含針對犬病的預防性醫療解決方案的犬疫苗市場預計將大幅成長。疫苗接種對於預防狂犬病、細小病毒和犬瘟熱等疾病至關重要，不僅可以保護您的寵物，還可以保護公眾健康。犬疫苗的應用範圍從普遍建議的核心疫苗到針對特定地區或狗的生活方式的非核心和專門疫苗。這些疫苗的最終用途廣泛在獸醫院、寵物醫院和流動獸醫醫院。市場成長受到寵物醫療保健需求增加、疫苗技術進步以及飼主對預防措施興趣增加等因素的顯著影響。在寵物擁有量不斷增加的新興市場以及開發簡化疫苗接種流程的組合疫苗方面，機會比比皆是。公司可以透過創新更易於管理的疫苗、提高功效並擴大分銷網路來利用這些機會。然而，市場開拓面臨疫苗研發高成本、監管複雜、疫苗抗藥性、飼主懷疑等挑戰。儘管很少見，但副作用也可能限制廣泛接受。為了克服這些挑戰，企業應專注於強而有力的研發，創新疫苗輸送系統並提高疫苗的安全性。市場競爭激烈，主要企業在不斷創新，透過多樣化的產品系列擴大市場佔有率。增加技術整合，例如人工智慧主導的個人化疫苗計劃資料分析，為未來探索提供了肥沃的土壤。上市公司也應考慮與政府機構和衛生組織合作，以加強公眾信任和監管合規性，並確保犬隻疫苗的接受度和應用呈上升趨勢。

主要市場統計
基準年[2023] 20.5億美元
預測年份 [2024] 22.1億美元
預測年份 [2030] 35.2億美元
複合年成長率（%） 8.03%

市場動態：快速發展的犬隻疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變犬疫苗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 寵物擁有量的增加以及動物健康和疫苗接種意識的提高
    • 支持強制性寵物疫苗接種和動物疾病控制的政府措施和法規
    • 通用感染疾病的興起以及疫苗在預防中的作用
    • 獸醫學的進步和寵物醫療基礎設施投資的增加
  • 市場限制因素
    • 缺乏飼主對狗狗疫苗接種重要性的認知與教育
    • 嚴格的監管要求和犬疫苗漫長的核准流程導致了疫苗的延誤。
  • 市場機會
    • 生物技術的進步導致開發出更有效的針對常見犬類疾病的疫苗
    • 加大研發投入，副作用較少的下一代狗疫苗
    • 動物用藥品公司與研究機構合作創造創新的疫苗解決方案
  • 市場挑戰
    • 應對犬隻疫苗核准和銷售監管環境的變化
    • 平衡犬疫苗產業不斷上升的研發和生產成本

波特的五力：駕馭狗狗疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解狗狗疫苗市場的外部影響

外部宏觀環境因素對狗疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解犬隻疫苗市場競爭狀況

對狗疫苗市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣犬疫苗市場供應商的績效評估

FPNV定位矩陣是評估狗狗疫苗市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了狗疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對狗疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 寵物數量不斷增加，動物健康和疫苗接種意識不斷增強
      • 支持寵物疫苗接種要求和動物疾病控制的政府措施和法規
      • 通用感染疾病發生率上升以及疫苗在預防中的作用
      • 獸醫學的進步和寵物醫療基礎設施投資的增加
    • 抑制因素
      • 寵物飼主缺乏對狗狗疫苗接種重要性的認知與教育
      • 狗疫苗嚴格的監管要求和漫長的核准流程導致延誤
    • 機會
      • 生物技術的進步導致開發出更有效的針對常見犬類疾病的疫苗
      • 加大研發投入，副作用較少的下一代狗疫苗
      • 動物用藥品公司與研究機構合作創造創新的疫苗解決方案
    • 任務
      • 應對犬隻疫苗核准和分銷不斷變化的法規環境
      • 平衡犬疫苗產業不斷上升的研究、開發和生產成本
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章以疫苗類型分類的狗狗疫苗市場

  • 核心疫苗
    • 犬腺病毒
    • 犬瘟熱病毒
    • 犬小病毒
    • 狂犬病
  • 非核心疫苗
    • 支氣管敗血博德氏菌
    • 伯氏疏螺旋體
    • 犬鉤端螺旋體

第7章狗疫苗市場：依技術分類

  • DNA疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗

第8章狗疫苗市場：依最終用戶分類

  • 動物醫院
  • 寵物診所
  • 調查機構
  • 獸醫診所

第9章狗疫苗市場：依通路分類

  • 網路藥房
  • 零售藥房
  • 疫苗接種營
  • 獸醫診所和醫院

第10章 狗狗疫苗市場：依應用分類

  • 疾病預防
  • 治療性的

第11章狗狗疫苗市場：依年齡層

  • 成年狗
  • 小狗
  • 老狗

第12章以狗體型分類的狗疫苗市場

  • 巨型物種
  • 大狗
  • 中型狗
  • 小狗

第13章美洲犬疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太狗疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章 歐洲、中東和非洲狗疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C028B

The Dog Vaccines Market was valued at USD 2.05 billion in 2023, expected to reach USD 2.21 billion in 2024, and is projected to grow at a CAGR of 8.03%, to USD 3.52 billion by 2030.

The market for dog vaccines, which encompasses preventive healthcare solutions targeted at canine diseases, is poised for significant growth due to increased pet ownership, rising awareness of animal health, and advancements in veterinary medicine. Vaccination is essential for preventing diseases like rabies, parvovirus, and distemper, safeguarding not just the pets but also public health. Applications of dog vaccines span core vaccines that are universally recommended to non-core and specialized vaccines intended for specific regions or canine lifestyles. End-use of these vaccines is prevalent in veterinary clinics, pet hospitals, and mobile veterinary units. Market growth is heavily influenced by factors like the escalating demand for pet healthcare, advances in vaccine technology, and increased focus on preventive measures among pet owners. Opportunities abound in developing markets with growing pet ownership and in creating combination vaccines that streamline the vaccination process. Companies can capitalize on these opportunities by innovating easy-to-administer vaccines, enhancing efficacy, and expanding their distribution networks. Nevertheless, the market faces challenges such as high costs associated with vaccine development, regulatory complexities, and occasional vaccine resistance and skepticism among pet owners. Adverse reactions, although rare, can also limit wider acceptance. To navigate these challenges, firms should focus on robust research and development initiatives, aiming at innovations in vaccine delivery systems, and improving vaccine safety profiles. The nature of the market is highly competitive, with continual innovation from key players aiming to expand their share through diversified product portfolios. Increasing technological integration, such as AI-driven data analytics for personalized vaccine schedules, represents fertile ground for future exploration. Companies should also consider collaborations with governmental and health agencies to enhance public trust and regulatory compliance, ensuring an upward trajectory in the acceptance and application of canine vaccines.

KEY MARKET STATISTICS
Base Year [2023] USD 2.05 billion
Estimated Year [2024] USD 2.21 billion
Forecast Year [2030] USD 3.52 billion
CAGR (%) 8.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dog Vaccines Market

The Dog Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing pet ownership and rising awareness about animal health and vaccinations
    • Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
    • Rising incidences of zoonotic diseases and the role of vaccines in prevention
    • Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
  • Market Restraints
    • Lack of awareness and education among pet owners about the importance of dog vaccination
    • Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
  • Market Opportunities
    • Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
    • Rising investment in research and development for next-generation dog vaccines with fewer side effects
    • Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
  • Market Challenges
    • Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
    • Balancing the rising costs of research, development, and production in the dog vaccine industry

Porter's Five Forces: A Strategic Tool for Navigating the Dog Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dog Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dog Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dog Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dog Vaccines Market

A detailed market share analysis in the Dog Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dog Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dog Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dog Vaccines Market

A strategic analysis of the Dog Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dog Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc., Bayer Animal Health GmbH, Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Hipra, IDEXX Laboratories, Inc., Intas Pharmaceuticals Ltd., Kyoritsu Seiyaku Corporation, Merck & Co., Inc., Merial Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Vaccine Type, market is studied across Core Vaccines and Non-Core Vaccines. The Core Vaccines is further studied across Canine Adenovirus, Canine Distemper Virus, Canine Parvovirus, and Rabies. The Non-Core Vaccines is further studied across Bordetella Bronchiseptica, Borrelia Burgdorferi, and Leptospira Canicola.
  • Based on Technology, market is studied across DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, and Recombinant Vaccines.
  • Based on End User, market is studied across Animal Hospitals, Pet Clinics, Research Institutes, and Veterinary Clinics.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Vaccination Camps, and Veterinary Clinics & Hospitals.
  • Based on Application, market is studied across Disease Prevention and Therapeutic.
  • Based on Age Group, market is studied across Adult Dogs, Puppies, and Senior Dogs.
  • Based on Dog Size, market is studied across Giant Breed, Large Breed, Medium Breed, and Small Breed.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing pet ownership and rising awareness about animal health and vaccinations
      • 5.1.1.2. Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
      • 5.1.1.3. Rising incidences of zoonotic diseases and the role of vaccines in prevention
      • 5.1.1.4. Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and education among pet owners about the importance of dog vaccination
      • 5.1.2.2. Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
      • 5.1.3.2. Rising investment in research and development for next-generation dog vaccines with fewer side effects
      • 5.1.3.3. Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
      • 5.1.4.2. Balancing the rising costs of research, development, and production in the dog vaccine industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dog Vaccines Market, by Vaccine Type

  • 6.1. Introduction
  • 6.2. Core Vaccines
    • 6.2.1. Canine Adenovirus
    • 6.2.2. Canine Distemper Virus
    • 6.2.3. Canine Parvovirus
    • 6.2.4. Rabies
  • 6.3. Non-Core Vaccines
    • 6.3.1. Bordetella Bronchiseptica
    • 6.3.2. Borrelia Burgdorferi
    • 6.3.3. Leptospira Canicola

7. Dog Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines
  • 7.4. Live Attenuated Vaccines
  • 7.5. Recombinant Vaccines

8. Dog Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Animal Hospitals
  • 8.3. Pet Clinics
  • 8.4. Research Institutes
  • 8.5. Veterinary Clinics

9. Dog Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Vaccination Camps
  • 9.5. Veterinary Clinics & Hospitals

10. Dog Vaccines Market, by Application

  • 10.1. Introduction
  • 10.2. Disease Prevention
  • 10.3. Therapeutic

11. Dog Vaccines Market, by Age Group

  • 11.1. Introduction
  • 11.2. Adult Dogs
  • 11.3. Puppies
  • 11.4. Senior Dogs

12. Dog Vaccines Market, by Dog Size

  • 12.1. Introduction
  • 12.2. Giant Breed
  • 12.3. Large Breed
  • 12.4. Medium Breed
  • 12.5. Small Breed

13. Americas Dog Vaccines Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Dog Vaccines Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Dog Vaccines Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aratana Therapeutics, Inc.
  • 2. Bayer Animal Health GmbH
  • 3. Biogenesis Bago
  • 4. Boehringer Ingelheim Animal Health
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma Group
  • 7. Dechra Pharmaceuticals PLC
  • 8. Elanco Animal Health Incorporated
  • 9. Heska Corporation
  • 10. Hipra
  • 11. IDEXX Laboratories, Inc.
  • 12. Intas Pharmaceuticals Ltd.
  • 13. Kyoritsu Seiyaku Corporation
  • 14. Merck & Co., Inc.
  • 15. Merial Ltd.
  • 16. Neogen Corporation
  • 17. Phibro Animal Health Corporation
  • 18. Vetoquinol S.A.
  • 19. Virbac S.A.
  • 20. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. DOG VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. DOG VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DOG VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DOG VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE DISTEMPER VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY BORDETELLA BRONCHISEPTICA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY BORRELIA BURGDORFERI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY LEPTOSPIRA CANICOLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY PET CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION CAMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY GIANT BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY LARGE BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY MEDIUM BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY SMALL BREED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. POLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 328. POLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. QATAR DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 337. QATAR DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. RUSSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 346. RUSSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 354. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 355. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 362. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 363. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 364. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 365. SPAIN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 366. SPAIN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 367. SPAIN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
  • TABLE 368. SPAIN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 369. SPAIN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 370. SPAIN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 371. SPAIN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 372. SPAIN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 373. SPAIN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
  • TABLE 374. SWEDEN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
  • TABLE 375. SWEDEN DOG VACCINES MARKET SIZE, BY C